the aid library

LIST OPTIONS

Filter

2356

Sort by:

Direction:

Download (1166)

View PDF (1300)

Using indicators to measure country pharmaceutical situations

WHO World Health Organization (WHO) (2006) C_WHO

Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ... more

Download (164)

View PDF (253)

HEARTS. Technical package for cardiovascular disease management in primary health care. Systems of Monitoring

World Health Organization WHO, et al. (2018) C_WHO

Monitoring is a crucial element in any successful programme. It is important to know if health care facilities – and ultimately countries – are meeting the agreed goals and objectives for preventing and managing cardiovascular diseases (CVD). Monitoring is the on-going collection, management ...and use of information to assess whether an activity or programme is proceeding according to plan and/ or achieving defined targets. Not all outcomes of interest can be monitored. Clear outcomes must be identified that relate to the most important changes expected to result from the project and to what is realistic and measurable within the timescale of the project. Once these outcomes have been articulated, indicators can be chosen that best measure whether the desired outcomes are being met. To allow progress to be monitored, this module provides a set of indicators on CVD management. Agreeing on a set of indicators allows countries to compare progress in CVD management and treatment across different districts or subnational jurisdictions, as well as at a facility level, identify where performance can be improved, and track trends in implementation over time. Monitoring these indicators also helps identify problems that may be encountered so that implementation efforts can be redirected. This module starts from the collection of data at facility level, which is then “transferred up” the system: facility-level data are aggregated at subnational level to produce reports that allow tracking of facility and subnational performance over time and allow for comparison among facilities. National-level data are obtained through population-based surveys. Implementing a monitoring system requires action at many levels. At national and subnational levels, staff can determine how best to integrate data elements into existing data collection systems – such as the routine service-delivery data that are collected through facility-level Health Management Information Systems (HMIS). In the facility setting, personnel must be aware of what data are needed. Sample data-collection tools are included, recognizing that countries use different datamanagement systems for HMIS, so the CVD monitoring tools will be adapted to work with the HMIS system being used by the country, such that the indicators can be collected with minimal disruption/work to existing systems and tools more

Download (569)

View PDF (1135)

Target Regimen Profiles for TB Treatment

World Health Organization WHO (2016) C_WHO

There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi... more

Download (218)

View PDF (354)

National Guidelines For Stem Cell Research

Indian Council of Medical Research & Department of Biotechnology (2017) C1

The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells... more

Download (1634)

View PDF (2143)

MSF Qualification Scheme for International Pharmaceutical Supply

Medicins Sans Frontieres (2009) CC

The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch... more

Download (583)

View PDF (2207)

International Maternal & Child Health Care - A practical manual for hospitals worldwide

Maternal & Childhealth Advocacy International (MCAI) , Advanced Life Support Group (ALSG) Radcliffe (2015) C2

The purpose of adding the books to the website of MCAI for download, is to make this life-saving, up-to-date information available to all who need it. Fill in a short registration field and you can download the pdf-files. If you work in a hospital in a low income country - providing free care - y... more

Download (419)

View PDF (1080)

Generic risk assessment model for insecticide-treated nets, 2nd ed.

World Health Organization (WHO) (2018) C_WHO

Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t... more

Download (395)

View PDF (920)

WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants

World Health Organization (WHO) (2003) C_WHO

The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli... more

Download (581)

View PDF (392)

Guidelines for Pharmacovigilance and Medicine Information System in Rwanda

Ministry of Health, Rwanda (2011) C2

The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to... more

Download (1507)

View PDF (2415)

A model quality assurance system for procurement agencies

World Health Organization World Health Organization, United Nations Children's Fund, United Nations Development Programme, United Nations Populations Fund, World Bank (2007) C_WHO

This interagency report provides recommendations for assuring quality of medicines during key activities of country-level procurement agencies, namely prequalification of pharmaceutical products and manufacturers; purchase of pharmaceutical products; storage of pharmaceutical products; and distribut... more

Download (89)

View PDF (156)

FEEDcities project: The food environment description in cities in Eastern Europe and Central Asia - Republic of Moldova

World Health OrganizationEurope (2017) C_WHO

This technical report contains the results from the FEEDcities Project – Eastern Europe and Central Asia, a cross-sectional survey of the local urban food environment conducted in Chișinău, Republic of Moldova between June and August 2016. It characterizes the vending sites, the food offered and... more

Download (99)

View PDF (113)

FEEDcities project. The food environment description in cities in Eastern Europe and Central Asia - Tajikistan

World Health Organization WHO, Regional Office of Europe (2017) CC

This technical report describes the results of a cross-sectional survey conducted in Dushanbe, Tajikistan, between April and May 2016, as part of the FEEDcities Project – Eastern Europe and Central Asia. The aim was to describe the local street food environment: the characteristics of the vending ... more

Download (140)

View PDF (135)

FEEDcities project: Food Environment Description in cities – eastern Europe and central Asia Sarajevo. The Federation of Bosnia and Herzegovina. Bosnia and Herzegovina (2019)

World Health Organization (2019) C_WHO

This technical report presents the results of a cross-sectional survey conducted in Sarajevo, the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina, between June and August 2017, as part of the FEEDcities Project (Food Environment Description in cities – eastern Europe and central Asia)... more

Download (144)

View PDF (232)

FEEDcities project A comprehensive characterization of the street food environment in cities (2019)

World Health Organization WHO (2019) C_WHO

Project protocol Introduction Ready-to-eat food sold in the street represents a global phenomenon, more common in urbanized areas, that constitutes an important dietary source in populations from low- and middle-income countries. However, research on the kind of street food offered and its composit... more

Download (93)

View PDF (121)

FEEDcities project. The food environment in cities in eastern Europe and Central Asia – Kazakhstan (2019)

World Health Organization (2019) C_WHO

This technical report presents results from the FEEDcities Project – Eastern Europe and Central Asia, a cross-sectional survey conducted in Almaty, Aktau and Kyzylorda, Kazakhstan, between July and August 2017, to evaluate the local street food environment. It characterized the vending sites, the ... more

Download (229)

View PDF (261)

Accelerating access to hepatitis C diagnostics and treatment

World Health Organization WHO (2021) C2

Overcoming barriers in low- and middle-income countries For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha... more

Download (290)

View PDF (344)

Regulatory guidance for assessment and management of applications for marketing authorization of oxytocin

World Health Organization WHO (2021) C_WHO

Pharmaceutical regulators are at the forefront of ensuring that only safe and effective medicines are authorized and available in the market. This document builds on the recommendations in the above publication and has been prepared to specifically assist national medicines regulatory authorities to... more

Download (71)

View PDF (429)

Guidance on operational microplanning for COVID-19 vaccination

World Health Organization WHO (2021) C_WHO

This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use of multiple vaccine products with different charact... more

Download (114)

View PDF (153)

Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial

Pohlig G, Bernhard SC, Blum J, Burri C, Mpanya A, et al. PLOS Neclected Tropical Diseases (2016) CC

This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita... more

Download (120)

View PDF (120)

A health promotion approach for reducing youth exposure to alcogenic environments: Snapshot series on alcohol policies and practice

World Health Organisation (WHO) (2023) C_WHO

The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term... more